Table 1.
Baseline Demographics and Comorbidities of Patients with Hospital Discharge Between January 20, 2020, and June 30, 2020, and Patients Who Acquired COVID-19 After Hospital Discharge
| Characteristic | Study Group (n = 101,533) | COVID-19 in Study Group (n = 44) | P Value |
|---|---|---|---|
| Age, median y ± SD | 51.4 ± 23.9 | 62.5 ± 14.1 | .002 |
| Sex, female, no. (%) | 51,505 (50.7) | 23 (52.2) | .83 |
| Race, no. (%) | |||
| White | 66,225 (65.2) | 26 (59.1) | .39 |
| Black | 24,794 (24.4) | 14 (31.8) | .25 |
| % of patients with comorbid conditions | |||
| Hypertensive | 56.7 | 86.3 | <.001 |
| Diabetes mellitus | 30.3 | 43.1 | .064 |
| Cnronic kidney disease | 22.0 | 40.9 | .002 |
| Ischemic heart | 28.1 | 38.6 | .122 |
| Congestive heart failure | 23.9 | 36.3 | .053 |
| Overweight | 23.8 | 31.8 | .214 |
| Chronic obstructive pulmonary disease | 15.9 | 29.5 | .013 |
| Asthma | 13.2 | 25.0 | .021 |
| Atrial fibrillation | 16.5 | 22.7 | .269 |
| Smoking | 22.1 | 22.7 | .921 |